FDA Probing Possible Link Between Asthma Drug and Suicide Risk

March 28, 2008

The U.S. Food and Drug Administration said Thursday it was investigating the possibility of an increased risk of mood changes and suicidal behavior among those who take the highly popular asthma drug Singulair. (HealthDay)